fluorodeoxyglucose f18 has been researched along with 4-hydroxymethylphenidate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brockmann, K; Globas, C; Hauser, TK; Machulla, HJ; Reimold, M; Rolfs, A; Schöls, L; Walter, U | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and 4-hydroxymethylphenidate
Article | Year |
---|---|
PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
Topics: Adult; Age of Onset; Brain; Dopamine Agents; Dopamine Antagonists; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Glucose; Heterozygote; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylphenidate; Middle Aged; Mutation; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Spinocerebellar Ataxias | 2012 |